RecruitingNot applicableNCT05735964

Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula

Studying Esophageal atresia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Birmingham Women's and Children's NHS Foundation Trust
Principal Investigator
Max Pachl
Birmingham Women's and Children's NHS Foundation Trust, UK
Intervention
Indocyanine green(drug)
Enrollment
20 target
Eligibility
1 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05735964 on ClinicalTrials.gov

Other trials for Esophageal atresia

Additional recruiting or active studies for the same condition.

See all trials for Esophageal atresia →

← Back to all trials